Clinical Trial

MagDI Australia Study

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The objective of the MagDI Australia Study is to evaluate the feasibility / performance, safety, and initial efficacy of the MagDI System in eligible participants who are indicated for a duodeno-ileal (small bowel) side-to-side anastomosis procedure for partial intestinal diversion (e.g., one example of a small bowel clinical procedure requiring a side-to-side anastomosis).
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2024-06-19; most recent amendment 2026-05-18.
Status change: Recruiting → Active, Not Recruiting 2025-07-18
Trial Details
NCT Number NCT06473831
Lead Sponsor GT Metabolic Solutions, Inc.
Conditions Obesity, Type 2 Diabetes
Enrollment 25 participants
Start Date 2024-08-13
Primary Completion 2025-09-04 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2026-05-20